Price Target Changed: MTS Systems (MTSC), Fossil Group (FOSL), ZIOPHARM Oncology (ZIOP), Apple Inc. (AAPL)

MTS Systems Corporation (MTSC) was reiterated a ‘Buy’ by Wunderlich analysts on Wednesday. The broker also cut its price target on the stock to $68 from $80.

MTSC shares recently lost $9.21 to $47.14. The stock is down 11.39% year-over-year and has lost roughly 10.66% year-to-date. In the past 52 weeks, shares of Eden Prairie Minnesota-based company have traded between a low of $46.62 and a high of $72.89.

MTS Systems Corp. closed Tuesday at $56.35. The name has a total market cap of $695.89 million.

MTSC stock chart

Fossil Group, Inc. (FOSL) was reiterated as ‘Buy’ with a $44 from $60 price target on Wednesday by Topeka Capital Markets.

FOSL is currently printing a higher than average trading volume with the issue trading 15.38 million shares, compared to the average volume of 1.03 million. The stock began trading this morning at $27.05 to currently trade 28.94% lower from the prior days close of $40.10. On an intraday basis it has gotten as low as $26.51 and as high as $29.69.

FOSL stock chart

ZIOPHARM Oncology, Inc. (ZIOP) rating of ‘Neutral’ was reiterated today at Mizuho with a price target increase of $7 from $6 (versus a $7.48 previous close).

ZIOP is up $0.68 at $8.16 on heavy volume. Midway through trading Wednesday, 4.36 million shares of ZIOPHARM Oncology have exchanged hands as compared to its average daily volume of 2.10 million shares. The stock ranged in a price between $7.23-$8.72 after having opened the day at $7.41 as compared to the previous trading day’s close of $7.48.

In the past 52 weeks, shares of Boston Massachusetts-based company have traded between a low of $4.56 and a high of $14.93. Shares are down 30.42% year-over-year and 9.99% year-to-date.

ZIOP stock chart

Shares of Apple Inc. (AAPL) are down $0.62 to $92.80 in mid-day trading after UBS reiterated its ‘Buy’ rating and decreased its 12-month base case estimate on the name by 5 points to $115 a share.

Apple Inc. shares are priced at 9.88x this year’s forecasted earnings, compared to the industry’s 10.23x earnings multiple. The company’s current year and next year EPS growth estimates stand at (10.1%) and 10.40% compared to the industry growth rates of (6.9%) and 13.50%, respectively. AAPL has a t-12 price-to-sales ratio of 2.20. EPS for the same period registers at $9.40.

AAPL shares have declined 13.79% in the last 4 weeks and 1.05% in the past three months. Over the past 5 trading sessions the stock has lost 1.25%.

The Cupertino California-based company, which is currently valued at $508.36 billion, has a median Wall Street price target of $120.00 with a high target of $185.00. Apple Inc. is down 24.53% year-over-year, compared with a 0.67% loss in the S&P 500.

AAPL stock chart

Be the first to comment

Leave a Reply

Your email address will not be published.


*